DK139356B - Fremgangsmåde til spaltning af DL-5-(3-(tert.-butylamino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)naphthalenon i dens optiske isomere og dannelse af hydrochloridsyreadditionssalte deraf. - Google Patents

Fremgangsmåde til spaltning af DL-5-(3-(tert.-butylamino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)naphthalenon i dens optiske isomere og dannelse af hydrochloridsyreadditionssalte deraf.

Info

Publication number
DK139356B
DK139356B DK417370AA DK417370A DK139356B DK 139356 B DK139356 B DK 139356B DK 417370A A DK417370A A DK 417370AA DK 417370 A DK417370 A DK 417370A DK 139356 B DK139356 B DK 139356B
Authority
DK
Denmark
Prior art keywords
naphthalenone
hydroxypropoxy
butylamino
dihydro
cleavage
Prior art date
Application number
DK417370AA
Other languages
Danish (da)
English (en)
Other versions
DK139356C (es
Inventor
John Shavel Jr
Charles Frederick Schwender
Original Assignee
Warner Lambert Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Pharmaceutical filed Critical Warner Lambert Pharmaceutical
Publication of DK139356B publication Critical patent/DK139356B/da
Application granted granted Critical
Publication of DK139356C publication Critical patent/DK139356C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK417370AA 1969-09-17 1970-08-13 Fremgangsmåde til spaltning af DL-5-(3-(tert.-butylamino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)naphthalenon i dens optiske isomere og dannelse af hydrochloridsyreadditionssalte deraf. DK139356B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85924469A 1969-09-17 1969-09-17

Publications (2)

Publication Number Publication Date
DK139356B true DK139356B (da) 1979-02-05
DK139356C DK139356C (es) 1979-08-20

Family

ID=25330421

Family Applications (1)

Application Number Title Priority Date Filing Date
DK417370AA DK139356B (da) 1969-09-17 1970-08-13 Fremgangsmåde til spaltning af DL-5-(3-(tert.-butylamino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)naphthalenon i dens optiske isomere og dannelse af hydrochloridsyreadditionssalte deraf.

Country Status (13)

Country Link
US (1) US3649691A (es)
JP (1) JPS494218B1 (es)
BE (1) BE755071A (es)
BR (1) BR7022215D0 (es)
CH (1) CH540882A (es)
DE (1) DE2046043C3 (es)
DK (1) DK139356B (es)
ES (1) ES383643A1 (es)
FR (1) FR2068537B1 (es)
GB (1) GB1264775A (es)
NL (1) NL7013663A (es)
NO (1) NO135141C (es)
ZA (1) ZA704981B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130393C3 (de) * 1970-06-22 1981-02-26 E.R. Squibb & Sons Inc., New York, N.Y. (V.St.A.) 6,7-Dihydroxy -5,6,7,8-tetrahydronaphthyloxyaminopropanole und ihre Salze mit Säuren sowie ihre Verwendung bei der Bekämpfung von Herzerkrankungen
GB1464950A (en) * 1973-05-03 1977-02-16 Squibb & Sons Inc Naphthalene derivatives
GB1458392A (en) * 1973-11-09 1976-12-15 Ici Ltd Optically-active 1-aryloxy-2,3-epoxypropane derivatives
CH621330A5 (es) * 1976-05-14 1981-01-30 Sandoz Ag
JPS5334024U (es) * 1976-08-31 1978-03-25
IT1113029B (it) * 1979-03-01 1986-01-20 Simes Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro
US5245080A (en) * 1989-02-20 1993-09-14 Jouveinal Sa (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
US5266599A (en) * 1989-02-20 1993-11-30 Jouveinal S.A. Use of (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine to increase gastric discharge in a subject
ES2065278B1 (es) * 1993-06-24 1995-09-01 Medichem Sa Procedimiento de obtencion enantioselectivo del levobunolol.
KR20110117731A (ko) * 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 ｈｍｇ―ｃｏ 억제제로서의 이의 용도
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
WO2008010087A2 (en) * 2006-07-14 2008-01-24 Ranbaxy Laboratories Limited Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2974148A (en) * 1959-03-30 1961-03-07 Smith Kline French Lab Anorexigenic preparation and method of curbing the appetite
US3641152A (en) * 1968-09-23 1972-02-08 Warner Lambert Pharmaceutical 3 4-dihydronaphthalenoneoxy-2-hydroxy-propylamines

Also Published As

Publication number Publication date
DE2046043A1 (de) 1971-03-25
JPS494218B1 (es) 1974-01-31
GB1264775A (es) 1972-02-23
CH540882A (de) 1973-08-31
ZA704981B (en) 1971-07-28
US3649691A (en) 1972-03-14
NO135141C (es) 1977-02-16
BE755071A (fr) 1971-02-22
DE2046043B2 (de) 1978-03-30
NO135141B (es) 1976-11-08
NL7013663A (es) 1971-03-19
BR7022215D0 (pt) 1973-04-26
ES383643A1 (es) 1976-06-01
DK139356C (es) 1979-08-20
DE2046043C3 (de) 1978-12-14
FR2068537A1 (es) 1971-08-27
FR2068537B1 (es) 1974-02-01

Similar Documents

Publication Publication Date Title
DK139356B (da) Fremgangsmåde til spaltning af DL-5-(3-(tert.-butylamino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)naphthalenon i dens optiske isomere og dannelse af hydrochloridsyreadditionssalte deraf.
DK125794B (da) Analogifremgangsmåde til fremstilling af 2,3-dichlorphenoxyeddikesyrederivater.
DK126236B (da) Fremgangsmåde til fremstilling af L-3,4-dihydroxyphenylalanintabletter.
DK134317B (da) I det væsentlige isomer ren N-substitueret beta-amino-alfa-benzylacrylonitrilforbindelse til anvendelse som mellemprodukt og fremgangsmåde til fremstilling af en sådan forbindelse.
DK133870B (da) Analogifremgangsmåde til fremstilling af substituerede phenoxycarboxylsyrederivater.
DK119878B (da) Analogifremgangsmåde til fremstilling af 2-methyl-3-carboxylsyreamido-quinoxalin-di-N-oxider-(1,4).
DK123029B (da) Fremgangsmåde til fremstilling af 3-hydroxy-2-imino-1 (2H)-pyridinsulfonsyre-monohydrat eller 2-amino-3-pyridinol.
DK136607B (da) Analogifremgangsmåde til fremstilling af menadion-bisulfitderivater.
DK125990B (da) Fremgangsmåde til fremstilling af 4,4'-ditiobis-(2,6-di-t-butylfenol).
DK133814B (da) Fremgangsmåde til fremstilling af slagfaste, vejrbestandige polymerisater af vinylchlorid.
DK135285B (da) Analogifremgangsmåde til fremstilling af 5-substituerede 5,10-dihydro-11H-dibenzo(b,e)(1,4)diazepin-11-oner eller 11-substituerede 5, 11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oner eller syreadditionssalte deraf.
DK118246B (da) Analogifremgangsmåde til fremstilling af 2-isothiuroniummethyl-3-carboxylsyreamido-quinozalin-di-N-oxid-(1,4)-halogenider.
NO763231L (no) Fremgangsm}te til fremstilling av 6beta,17-dihydroksy-7alfa-(lavere alkoksy)karbonyl-3-okso-17alfa-pregn-4-en-21-karboksylsyre gamma-laktoner.
DK130000B (da) Fremgangsmåde til fremstilling af 9-oxo-6,9-dihydro-4 H-dioxino [4,5-g] quinoleyl-8-carboxylsyrer og deres isomere 10-oxo-7,10-dihydro-1 H-dioxino [5,4-f] quinoleyl-9-carboxylsyrer.
DK124880B (da) Fremgangsmåde til fremstilling af Δ<1,3,5(10)>-steroider af østranrækken.
DK126105B (da) Fremgangsmåde til fremstilling af meget ren 2,6-xylenol.
DK123292B (da) Fremgangsmåde til fremstilling af (1R,2R)-d-trans-pyrethrinsyre.
DK137190B (da) Fremgangsmåde til fremstilling af 6beta-amino-2,2-dimetylpenam-3alfa-karboxylsyre.
DK125083B (da) Fremgangsmåde til fremstilling af 2,3-diklor-4-butyryl-fenoxyeddikesyre.
DK125790B (da) Fremgangsmåde til fremstilling af L-β-3,4-dihydroxyphenyl-α-alanin.
DK126186B (da) Fremgangsmåde til fremstilling af 13β-alkylgona-4,9-diener.
DK107160C (da) Fremgangsmåde til fremstilling af 5H-dibenzo[a,d]cycloheptener eller syreadditionssalte deraf.
DK126941B (da) Fremgangsmåde til fremstilling af 1,4-dihydro-1,4-etheno-isoquinolin-3(2H)-oner.
DK64934C (da) Fremgangsmaade til Fremstilling af 4,4'-disubstituerede Difenylsulfonderivater.
DK135718B (da) Analogifremgangsmåde til fremstilling af 3-methylquinoxalin-1,4-dioxid-2-carboxylsyre-chlorethylamid.